Inventor

Mannching Sherry Ku

Inventor
Thiells, NY, US

Overview

17→
Patents
1996–2018
Patent span
Human necessities
Primary field (CPC A)

Patents· 17 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
A61KPreparations for medical, dental or toiletry purposes24%
C07DHeterocyclic compounds22%
C07CAcyclic or carbocyclic compounds14%
A61NElectrotherapy2%
C07BGeneral methods of organic chemistry2%
C07KPeptides2%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests2%
PatentTitleYear
10,035,788Maleate salts of (E)-N-{4[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereof20189,630,946'Maleate salts of (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereof'20179,139,558'Maleate salts of (E)-N-{4-[3-Chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereof'20158,865,689'Methods and compositions for treating hyperuricemia and metabolic disorders associated with hyperuricemia'20148,846,758'Methods of decreasing glycosylated hemoglobin in patients with dyslipidemia'20148,536,152'Methods of using diacerein as an adjunctive therapy for diabetes'20138,394,959'Maleate salts of (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl)-4-(dimethylamino)-2-buteramide and crystalline forms thereof'20138,372,995'Crystalline solid forms of tigecycline and methods of preparing same'20138,183,201'Methods of treating αvβ3 integrin-associated diseases by administering polypeptides selective for αvβ3 integrin'20128,173,814'Maleate salts of (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereof'20128,114,869'Polymorph form II of tanaproget'20128,022,216'Maleate salts of (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereof'20117,968,709'Process for preparing polymorph form II of tanaproget'20117,759,341'Polymorph form II of tanaproget'20107,683,182'Crystal forms of 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-ol'20107,419,982'Crystalline forms of 5-chloro-6-{2,6-difluoro-4-[3-(methylamino)propoxy]phenyl}-N-[(1S)-2,2,2-trifluoro-1-methylethyl][1,2,4]triazolo[1,5-a]pyrimidin-7-amine salts'20085,561,121'Stable lyophilized thiotepa composition'1996

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1996Based in Rockland, NY, US· patent location history
2008–2018Based in Thiells, NY, US· patent location history
2010–2018Patents assigned to WYETH LLC (11)· patent assignee history
2012–2014Patents assigned to KU MANNCHING SHERRY (8)· patent assignee history
2013–2014Patents assigned to LIN I-YIN (3)· patent assignee history
2013–2014Patents assigned to LU WEI-SHU (3)· patent assignee history
2013–2014Patents assigned to TWI BIOTECHNOLOGY INC (3)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
WYETH LLC112010–2018
KU MANNCHING SHERRYself82012–2014
LIN I-YIN32013–2014
LU WEI-SHU32013–2014
TWI BIOTECHNOLOGY INC32013–2014
Locations
LocationPatentsSpan
Thiells, New York, US162008–2018
Rockland, New York, US11996